1、S-1/A 1 d186104ds1a.htm S-1/ATable of ContentsAs filed with the Securities and Exchange Commission on January 3,2022.Registration No.333-261230UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Amendment No.1toFORM S-1REGISTRATION STATEMENTUnderThe Securities Act of 1933VIGIL NEUROSC
2、IENCE,INC.(Exact name of registrant as specified in its charter)Delaware 2836 85-1880494(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)1 Broadway,7th Floor,Suite 07-300Cambridge,MA 02142(857)254
3、-4445(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Ivana Magovevi-Liebisch1 Broadway,7th Floor,Suite 07-300Cambridge,MA 02142(857)254-4445(Name,address,including zip code,and telephone number,including area code,of agent for service)C
4、opies to:Kingsley L.TaftJacqueline MercierGabriela Morales-RiveraGoodwin Procter LLP100 Northern AvenueBoston,MA 02210(617)570-1000 Jennifer ZiolkowskiVigil Neuroscience,Inc.1 Broadway,7th Floor,Suite 07-300Cambridge,MA 02142(857)254-4445 Tara FisherPaul KinsellaRopes&Gray LLP800 Boylston StreetBost
5、on,MA 02199(617)951-7000Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
6、the Securities Act of 1933,asamended,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following box and list the SecuritiesAct registration statement number of the earlier effective regist